The use of a wearable cardioverter defibrillator for a patient after coronary artery bypass grafting to protect against sudden cardiac death. The first case in Poland

被引:0
|
作者
Baczewski, Kamil [1 ]
Stadnik, Adam [1 ]
Stazka, Janusz [1 ]
机构
[1] Med Univ Lublin, Dept Cardiac Surg, Lublin, Poland
关键词
ESC GUIDELINES;
D O I
10.5114/kitp.2024.141155
中图分类号
R61 [外科手术学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:129 / 131
页数:3
相关论文
共 50 条
  • [41] Usefulness of serial radionuclide angiography in predicting cardiac death after coronary artery bypass grafting and comparison with clinical and cardiac catheterization data
    BorgesNeto, S
    Shaw, LJ
    Kesler, K
    Sell, T
    Peterson, ED
    Coleman, RE
    Jones, RH
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (07): : 851 - 855
  • [42] Avatrombopag Use in Patient With Thromboembolic Risks Listed for Combined Coronary Artery Bypass Grafting and Liver Transplant: A Case Report
    Almalki, Bassem
    Shroff, Hersh
    Maddur, Haripriya
    Caicedo, Juan
    Kane, Clare
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (08) : 2567 - 2569
  • [43] Case 2-Sudden Death after Coronary Artery Bypass Surgery in a 49-year-old Female, Diabetic, Dyslipidemic, Hypertensive, Obese Patient
    Miranda, George Barreto
    Aiello, Vera Demarchi
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2013, 100 (05) : E54 - E58
  • [44] Cardiac enzyme elevations after coronary artery bypass grafting associated with increased risk of death: Results from PARAGON-B
    Mahaffey, KW
    Roe, MT
    Sparapani, R
    Dyke, CB
    Alexander, JH
    Berdan, LG
    Granger, CB
    Ohman, M
    Califf, RM
    Topol, EJ
    Harrington, RA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 359A - 359A
  • [45] Levosimendan Use Increases Cardiac Performance after Coronary Artery Bypass Grafting in End-Stage Renal Disease Patients
    Atalay, Hakan
    Temizturk, Zeki
    Altinsoy, Hasan Baki
    Azboy, Davut
    Colak, Salih
    Atalay, Atakan
    Dogan, Omer Faruk
    HEART SURGERY FORUM, 2016, 19 (05): : E230 - E236
  • [46] Therapeutic Hypothermia Following Emergent Coronary Artery Bypass Grafting After Failed Percutaneous Coronary Intervention in a Comatose Post-Cardiac Arrest Patient
    Choi, Seung Pill
    Wee, Jung Hee
    Park, Jeong Ho
    Park, Kyu Nam
    Hong, Sung Jin
    Lee, Sun Hee
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2013, 28 (08) : 1257 - 1259
  • [47] Mechanisms of death in the CABG Patch trial - A randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery
    Bigger, JT
    Whang, W
    Rottman, JN
    Kleiger, RE
    Gottlieb, CD
    Namerow, PB
    Steinman, RC
    Estes, NAM
    CIRCULATION, 1999, 99 (11) : 1416 - 1421
  • [48] MEDICAL PROBLEMS AND PHYSIOLOGIC RESPONSES DURING SUPERVISED INPATIENT CARDIAC REHABILITATION - THE PATIENT AFTER CORONARY-ARTERY BYPASS-GRAFTING
    DION, WF
    GREVENOW, P
    POLLOCK, ML
    SQUIRES, RW
    FOSTER, C
    JOHNSON, WD
    SCHMIDT, DH
    HEART & LUNG, 1982, 11 (03): : 248 - 255
  • [49] Anesthesia management using remimazolam for coronary artery bypass grafting and aortic valve replacement in a patient with severe cardiac dysfunction: A case report
    Sagawa, Tomoki
    Ishida, Yusuke
    Sasaki, Tomomi
    Hosokawa, Maiko
    Bito, Kiyoko
    Oe, Katsunori
    SAGE OPEN MEDICAL CASE REPORTS, 2024, 12
  • [50] NON HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IS A PRACTICAL PREDICTOR FOR LONG-TERM CARDIAC DEATH AFTER CORONARY ARTERY BYPASS GRAFTING
    Fukushima, Y.
    Ohmura, H.
    Mokuno, H.
    Kasai, T.
    Miyauchi, K.
    Amano, A.
    Daida, H.
    CARDIOLOGY, 2013, 126 : 513 - 513